Registration of Medical Devices According to EAEU Rules

Discover how to legally place your medical devices on the unified market of the Eurasian Economic Union (EAEU) by following a single regulatory procedure that covers Russia, Belarus, Kazakhstan, Armenia, and Kyrgyzstan.

Why Registration According to EAEU Rules Is So Important

The transition to common standards has unified key safety, quality, and efficacy requirements for medical products across all EAEU member states. Before this standardization, manufacturers had to navigate separate national rules and obtain multiple individual certificates. Now, by working with a single “reference state” (the country that performs the primary evaluation), a manufacturer or authorized representative can achieve approval for product circulation in all other EAEU countries (the so-called recognition states). This single process brings several advantages:

• Time and cost savings: You no longer need to carry out multiple independent registrations in each separate market.
• Unified technical requirements: EAEU rules stipulate consistent criteria for technical documents, testing procedures, and clinical evidence.
• Avoidance of duplicate processes: Once a reference state issues a registration certificate, the remaining EAEU member states accept it in a simplified manner.
• Accelerated regional expansion: A single regulatory approval opens the door to several markets simultaneously, boosting market presence and revenue potential.

However, COVID-19 has brought about temporary legal adjustments that manufacturers should keep in mind, including simplified procedures for certain categories of medical products (like personal protective equipment). Awareness of these details can help applicants optimize their registration strategy and expedite access to the unified market.

Key Terms and Participants in the EAEU Registration Process

To better understand how the registration of medical devices according to EAEU rules takes place, it helps to clarify several important definitions and roles in this regulatory framework.

Reference State

The reference state is the primary EAEU country whose regulatory body (for instance, Roszdravnadzor in Russia) carries out the main expert review and determines whether to grant a registration certificate. The applicant (manufacturer or authorized representative) files the complete dossier in this state first, initiating the detailed evaluation of safety, effectiveness, and compliance with EAEU standards.

Recognition State

A recognition state is any other EAEU member country besides the reference state. Once the reference state issues a positive decision, the recognition states accept that result and authorize the circulation of the same device on their territory through a streamlined procedure. This allows the product to be marketed in all participating nations without undergoing full, repeated evaluations.

Registration Certificate (RC)

Also called a Registration Certificate or RC, this is the official document proving that a medical device has passed all required checks under EAEU or national rules. Once the device is registered according to the EAEU regulations, the certificate grants access to every EAEU member state. In the legacy system of purely national regulations, separate registrations had to be obtained in each country. But under the EAEU framework, a single RC covers them all.

Registration Dossier

The registration dossier is the comprehensive document set that the applicant must submit to the reference state’s authority (e.g., Roszdravnadzor). It typically includes technical descriptions, test results (toxicological, clinical when required), proof of quality and safety, manufacturer details, labeling, and other relevant data. Properly assembling and validating all these materials is essential for a smooth registration process.

Regulatory Documents Governing EAEU Registration

The pivotal regulatory act is Decision No. 46 of the Council of the Eurasian Economic Commission (EEC) dated February 12, 2016, which defines the fundamental requirements for the registration of medical devices. Other important documents further clarify these standards:

• EEC Board Order No. 176 of November 12, 2018: Regulates the participation of accredited testing bodies in evaluating medical devices for EAEU circulation.
• EEC Board Decision No. 135 of August 21, 2018: Details specific requirements for the contents of the registration dossier.
• EEC Board Recommendation No. 14 of May 21, 2019: Describes the mandatory expert review procedure that validates device safety, declared characteristics, and efficacy.
• EEC Board Order No. 56 of April 2, 2019: Outlines the rules for maintaining the registry of approved medical devices.

During the COVID-19 pandemic, additional legal measures were introduced to facilitate market access for personal protective equipment (PPE), ventilators, test kits, and other critical items. These rules brought temporary simplifications and shorter review periods, though many of these measures carried time limits or applied only to specific device categories.

Major Steps in the EAEU Registration Process

While specific details may vary based on the risk class of the device (e.g., Class 2a, 2b, or 3) and the type of product, the overall workflow remains relatively uniform. Below are the central steps:

Selecting the Reference State

The manufacturer or its authorized representative decides in which EAEU country to initiate the registration. Russia is a frequent choice, given the established network of accredited laboratories and well-developed interaction with expert centers. Nonetheless, any EAEU member state can act as the reference state.

Submitting the Application and Documents

The applicant prepares the registration dossier, which contains technical materials, clinical data (if required), toxicology reports, safety assessments, and evidence of compliance with EAEU standards. Once complete, the dossier is submitted to the relevant authority of the reference state (Roszdravnadzor in Russia, for example). The thoroughness and accuracy of this dossier are vital to minimizing review delays.

Expert Evaluation

Accredited bodies validate the completeness and reliability of the registration dossier. They examine laboratory testing data, ensure that clinical and toxicological evidence matches the declared indications, and verify compliance with EAEU regulations. If deficiencies are found during the preliminary review, the applicant receives requests for additional information or corrections. Timely responses to these queries help avoid significant holdups.

Issuance or Refusal of a Registration Certificate

Once the reference authority finishes its review, it either grants the RC or issues a refusal. A positive result includes adding the device to the official registry. If there is a negative decision, the applicant may address the issues identified and reapply. Proper documentation and clarity are critical to securing approval the first time. If you receive a refusal, understanding the refusal letter from Roszdravnadzor can help you plan your next steps effectively.

Recognition Procedure

If the manufacturer intends to market the device not only in the reference state but also in other EAEU countries, it files a notice seeking recognition of the RC in the remaining member states. Recognition is typically faster and less costly than conducting the entire process anew in each country, as these states primarily rely on the reference authority’s conclusions.

Transition Period: Parallel Registration Under National and EAEU Rules

Until December 31, 2021, there was a transition period allowing applicants to choose between EAEU rules and existing national regulations. In Russia, that meant following Government Decree No. 1416. The transition was introduced to help manufacturers adapt to the new unified standards. Key points of this parallel framework included:

• Prior to the end of 2021, it was permissible to submit registrations under national rules and obtain registration certificates valid indefinitely.
• Applicants who obtained national approval before that deadline could continue to use that certificate within Russia for as long as it remained valid.
• To market across multiple EAEU countries, however, companies were encouraged to switch to the unified format eventually. National certificates typically did not grant automatic access to other member states.

Although the formal transition period ended, certain exceptions remained in effect due to COVID-19. This provided a measure of flexibility to manufacturers dealing with urgent pandemic-related devices or those who missed earlier filing opportunities.

COVID-19 Changes: Regulatory Relief for Protective Devices

As the pandemic spread, government bodies introduced expedited pathways to accelerate the availability of crucial medical products. This relief targeted two main categories:

• Protective equipment: Such as masks, gloves, respirators, filters, and protective suits.
• Diagnostic items for COVID-19: Including test kits, reagents, and other related consumables.

In Russia, for instance, Government Decrees No. 299 of March 18, 2020, and No. 430 of April 3, 2020, established simplified rules for registering certain critical products. These steps enabled manufacturers to reach the market swiftly. However, many of the resulting certificates carried limited validity—some expired on January 1, 2022, or January 1, 2025—after which conventional or EAEU-based re-registration was required.

Temporary Certificates and Their Re-Registration

Two main forms of temporary registration were offered during the height of COVID-19:

• Accelerated procedure: The agency issued a short-term certificate (e.g., valid for five months), during which the manufacturer had to finalize any missing tests and confirm the device’s performance.
• Simplified registration: This applied to specific products listed as crucial for infection control (like certain PPE). Certificates granted under this route also carried limited validity, and manufacturers needed to acquire a permanent RC afterward using the standard approach.

If a temporary RC expired after December 31, 2021, and the device was sold only in Russia, certain legal exemptions allowed an extension under Russian laws. Otherwise, to maintain or expand market presence beyond Russia, it became necessary to pursue a comprehensive EAEU registration.

Re-Registration Under Preferential Terms Until 2026

EEC Board Order No. 142 dated September 2, 2019, stipulates that for five years following the transition period, manufacturers may re-register devices previously given temporary certificates. This approach supports businesses that did not immediately switch to EAEU rules but now wish to tap into the unified market’s benefits. Important points include:

• If the device was on the protective product list (e.g., under Decree No. 299) and had a temporary RC dated before December 31, 2021, the manufacturer can choose to extend it under Russian national rules or transition to the EAEU format.
• In either case, any missing tests (toxicological, technical, clinical) must be performed and documented to ensure regulatory compliance.
• For companies aiming to market devices in several EAEU countries, it generally proves more cost-effective to register directly under EAEU standards to gain immediate multi-country access.

One of the main advantages of this “preferential” re-registration scheme is not having to start from scratch. As long as the criteria are satisfied, businesses can convert temporary or national approvals into an EAEU-compliant certificate by providing the required data and undergoing an appropriate expert review.

What the EAEU Registration Dossier Includes

The structure of the registration dossier for EAEU submission follows a formal template. Generally, the following items must be included:

• Application from the manufacturer or authorized representative: The applicant must be a legal entity resident in an EAEU member state.
• Technical documentation: Detailed descriptions of construction, materials, and principles of operation.
• Conformity evidence: Certificates like ISO 13485 or an equivalent standard, if available, demonstrating that your quality management system meets recognized benchmarks.
• Testing protocols: These may encompass technical, toxicological, and clinical data, depending on the device’s risk category (for example, Class 2b and Class 3 typically require clinical evaluations).
• Safety and efficacy data: This demonstrates the product’s reliability and verifies that the stated performance claims are justified.
• Manufacturing process details: A description of how the device is made, including quality control steps, raw materials used, and relevant procedures.
• User manual or instructions for use: Draft or final versions in the official language of the reference state (Russian is mandatory in Russia), complete with all required labeling elements.

All documents must be supplied in Russian (or accompanied by a certified, notarized translation), as mandated by the reference state’s regulations. Compliance with these rules—and ensuring every part of the dossier is carefully aligned with EEC Board guidelines—plays a huge role in securing timely approval. For assistance with this complex process, our medical device documentation development services can provide invaluable support.

How Experts Can Assist

Registering medical devices according to EAEU rules often demands navigating complex legal requirements and cooperating with multiple state agencies. Unified Center of Expertise and Certification “Quality” (UCEC QUALITY) specializes in guiding manufacturers and applicants through each stage. Our services include:

• Consultations: Our team explains exactly which documents are needed based on a device’s risk class and intended use. We offer advice on any supplementary testing that may be necessary.
• Dossier preparation: Experts compile all technical, clinical, and legal documents in the correct format, ensuring completeness and compliance with EEC Board decisions.
• Facilitating laboratory tests: We arrange technical, toxicological, and clinical trials with accredited labs, which is especially crucial for innovative or higher-risk devices.
• Legal support: If the regulator (e.g., Roszdravnadzor) requests clarifications or additional data, we handle responses and file updates within prescribed deadlines, minimizing the risk of rejections or prolonged review times.
• Re-registration and updating approvals: For companies holding temporary or nationally issued certificates, UCEC QUALITY helps convert them into EAEU-approved RCs or extends them under local rules (where legislation permits).

Why You Should Not Delay Document Preparation

Following the end of the official transition period, established medical device manufacturers and newcomers alike have recognized the importance of switching fully to EAEU norms or ensuring their national registration remains compliant. Securing EAEU registration delivers tangible benefits:

• Broad market access: Once approved in the reference state, the device is recognized in all EAEU countries, expanding business prospects with minimal extra steps.
• Greater stability: Unified regulations protect manufacturers from sudden shifts in local policies within a single member state.
• Reduced duplication: One expert review process typically replaces multiple individual reviews that would have been necessary under each nation’s separate laws.

Delaying the transition can mean facing gaps in legal status, which can disrupt product importation and sales, negatively impacting both revenue and brand image. By initiating EAEU registration or converting temporary approvals into EAEU-compliant ones, companies can secure a stable, long-term position in a significant multinational market.